Gladstone NOW: The Campaign Join Us on the Journey ✕
421 - 429 of 429 Results Clear All
The Washington Post—Gladstone President Deepak Srivastava comments in the Washington Post on a new study that debunks controversial stem cell procedures.
Gladstone Experts Srivastava Lab
10x Genomics—In order to understand how and why congential heart defects happen, Gladstone researchers used single cell RNA sequencing to characterize heart development. This study, led by Deepak Srivastava, is featured in the 10x Genomics blog.
Gladstone Experts
Gladstone scientists are taking a variety of approaches to find a cure for HIV
Gladstone Experts HIV/AIDS Center for HIV Cure Research Genomic Immunology Infectious Disease Doudna Lab Greene Lab Ott Lab Weinberger Lab
The Stem Cellar—In a CIRM-funded study, a Gladstone team led by Senior Investigator Todd McDevitt discover a way to to use machine learning to control the spacial organization of stem cells, a key process that plays a vital role in organ development.
Gladstone Experts McDevitt Lab
Cosmos—A team, led by Senior Investigator Todd McDevitt, used machine learning to overcome one of the major stumbling blocks in the creating of mini-organs. Read more about their study in Cosmos Magazine.
Gladstone Experts McDevitt Lab
Nature—A recent study, led by Senior Investigator Warner Greene, is featured in Nature’s Research Highlights. In the paper, researchers at Gladstone collaborated with Xyphos Biosciences, Inc. to develop a novel immunotherapy for HIV.
Gladstone Experts Greene Lab
Biocentury—Biocentury highlights a recent collaboration between the lab of Warner Greene and Xyphos to direct the company’s universal CAR Ts to cells latently infected with HIV, addressing several of the challenges CAR Ts have faced in the indication.
Gladstone Experts Greene Lab
Gladstone investigators call for caution and ethical oversight
Gladstone Experts Genomic Immunology Data Science and Biotechnology Conklin Lab Doudna Lab McDevitt Lab CRISPR/Gene Editing
San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.
Gladstone Experts HIV/AIDS
